Non-Squamous Non-Small Cell Lung Cancer Completed Phase 1 / 2 Trials for Erlotinib (DB00530)

Also known as: Non-small cell lung cancer / Non-small cell lung cancer NOS / Carcinoma, Non-Small-Cell Lung

DBCOND0036730 (Non-Squamous Non-Small Cell Lung Cancer)Completed1 / 2 IdentifierTitlePurposeDrugs
NCT01801111A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib TreatmentTreatment